Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis

Most prostate cancer cases remain indolent for long periods of time, but metastatic progression quickly worsens the prognosis and leads to mortality. However, little is known about what promotes the metastasis of prostate cancer and there is a lack of effective prognostic indicators, making it immen...

Descripción completa

Detalles Bibliográficos
Autores principales: Birnbaum, Michael D., Zhao, Ning, Moorthy, Balaji T., Patel, Devang M., Kryvenko, Oleksandr N., Heidman, Laine, Kumar, Akhilesh, Morgan, William M., Ban, Yuguang, Reis, Isildinha M., Chen, Xi, Gonzalgo, Mark L., Jorda, Merce, Burnstein, Kerry L., Zhang, Fangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368462/
https://www.ncbi.nlm.nih.gov/pubmed/30177837
http://dx.doi.org/10.1038/s41388-018-0462-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368462/
https://www.ncbi.nlm.nih.gov/pubmed/30177837
http://dx.doi.org/10.1038/s41388-018-0462-2

Ejemplares similares